ChemoCentryx Inc
CCXINASDAQFinancial Services·US · USD
$15.96
-0.23 (-1.42%)
Prices as of August 13, 2026 · livePrice
Key statistics
Valuation
Market cap901.78M USD
Enterprise value911.40M USD
Trailing P/E-8.76
Forward P/E-69.32
PEG ratio0.08
Price / sales28.27
Price / book2.29
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin99.05%
Return on assets-31.68%
Return on equity-32.96%
Income (TTM)
Revenue31.90M USD
Gross profit31.60M USD
EBITDA0.00 USD
Net income655.02K USD
Diluted EPS-$1.89
Rev. growth (YoY)0.00%
Balance sheet
Total cash410.10K USD
Total debt0.00 USD
Debt / equity0.00
Current ratio8.13
Book value / share-$0.25
Cash flow (TTM)
Operating cash flow-1.08M USD
Levered free cash flow-131.75M USD
Shares & price
Shares outstanding55.70M
Float41.40M
Held by institutions80.47%
Beta0.00
50-day MA$13.76
200-day MA$11.59
52-week high$19.69
52-week low$10.07
Dividends
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-07-282.802.84+1.43%2026-04-161.151.15+0.00%2026-03-11-1.30-1.72−32.31%2022-05-05-0.31-0.55−77.42%2022-03-01-0.58-0.58+0.00%
About ChemoCentryx Inc
Churchill Capital Corp XI does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in New York, New York.
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Mr. Michael S. Klein
- Employees
- 178
- Headquarters
- New York, NY, United States
- Website
- churchillcapital-11.com